{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:48:49Z","timestamp":1790279329130,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100002243","name":"National Ataxia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002243","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MINDlink Foundation"},{"DOI":"10.13039\/501100001058","name":"Fulbright Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01 NS104326"],"award-info":[{"award-number":["U01 NS104326"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-022-01424-1","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T17:03:28Z","timestamp":1660323808000},"page":"790-809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The S-Factor, a New Measure of Disease Severity in Spinocerebellar Ataxia: Findings and Implications"],"prefix":"10.1007","volume":"22","author":[{"given":"Louisa P.","family":"Selvadurai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Wilmot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sub H.","family":"Subramony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Ashizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry L.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiadi U.","family":"Onyike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana S.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haris I.","family":"Sair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Han","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Ratai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa A.","family":"Zesiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalaf O.","family":"Bushara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclin","family":"\u00d6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Dietiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Geschwind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra B.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Opal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talene A.","family":"Yacoubian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy C.","family":"Nopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram G.","family":"Shakkottai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla P.","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan M.","family":"Pulst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0706-5125","authenticated-orcid":false,"given":"Jeremy D.","family":"Schmahmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"issue":"1","key":"1424_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/1750-1172-8-177","volume":"8","author":"T Ashizawa","year":"2013","unstructured":"Ashizawa T, Figueroa KP, Perlman SL, Gomez CM, Wilmot GR, Schmahmann JD, Ying SH, Zesiewicz TA, Paulson HL, Shakkottai VG, Bushara KO, Kuo S-H, Geschwind MD, Xia G, Mazzoni P, Krischer JP, Cuthbertson D, Holbert A, Ferguson JH, et al. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet Journal of Rare Diseases. 2013;8(1):177. https:\/\/doi.org\/10.1186\/1750-1172-8-177.","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"1424_CR2","doi-asserted-by":"crossref","unstructured":"Cancel G, Gourfinkel-An I, Stevanin G, Didierjean O, Abbas N, Hirsch E, Agid Y, Brice A. Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3\/Machado-Joseph disease. Hum Mutat. 1998;11(1):23\u20137.\u00a0\u00a0https:\/\/doi.org\/10.1002\/(SICI)1098-1004(1998)11:1<23::AID-HUMU4>3.0.CO;2-M","DOI":"10.1002\/(SICI)1098-1004(1998)11:1<23::AID-HUMU4>3.3.CO;2-Y"},{"key":"1424_CR3","unstructured":"Casey HL, Gomez CM (1993). Spinocerebellar Ataxia Type 6. In M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. Bean, G. Mirzaa, & A. Amemiya (Eds.), GeneReviews\u00ae. University of Washington, Seattle. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1140\/"},{"key":"1424_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105311","volume":"153","author":"G Coarelli","year":"2021","unstructured":"Coarelli G, Darios F, Petit E, Dorgham K, Adanyeguh I, Petit E, Brice A, Mochel F, Durr A. Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia. Neurobiol Dis. 2021;153:105311. https:\/\/doi.org\/10.1016\/j.nbd.2021.105311.","journal-title":"Neurobiol Dis"},{"key":"1424_CR5","doi-asserted-by":"publisher","unstructured":"Cohen J (1988). Statistical Power Analysis for the Behavioral Sciences (2nd ed.). Routledge. https:\/\/doi.org\/10.4324\/9780203771587","DOI":"10.4324\/9780203771587"},{"key":"1424_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.mito.2017.03.001","volume":"34","author":"N Cornelius","year":"2017","unstructured":"Cornelius N, Wardman JH, Hargreaves IP, Neergheen V, Bie AS, T\u00fcmer Z, Nielsen JE, Nielsen TT. Evidence of oxidative stress and mitochondrial dysfunction in spinocerebellar ataxia type 2 (SCA2) patient fibroblasts: effect of coenzyme Q10 supplementation on these parameters. Mitochondrion. 2017;34:103\u201314. https:\/\/doi.org\/10.1016\/j.mito.2017.03.001.","journal-title":"Mitochondrion"},{"issue":"2","key":"1424_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/jnnp-2018-319200","volume":"90","author":"EP de Mattos","year":"2019","unstructured":"de Mattos EP, Kolbe Musskopf M, Bielefeldt Leotti V, Saraiva-Pereira ML, Jardim LB. Genetic risk factors for modulation of age at onset in Machado-Joseph disease\/spinocerebellar ataxia type 3: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2019;90(2):203\u201310. https:\/\/doi.org\/10.1136\/jnnp-2018-319200.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"1424_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/mdc3.12804","volume":"6","author":"DK Deelchand","year":"2019","unstructured":"Deelchand DK, Joers JM, Ravishankar A, Lyu T, Emir UE, Hutter D, Gomez CM, Bushara KO, Lenglet C, Eberly LE, \u00d6z G. Sensitivity of volumetric magnetic resonance imaging and magnetic resonance spectroscopy to progression of spinocerebellar ataxia type 1. Movement Disorders Clinical Practice. 2019;6(7):549\u201358. https:\/\/doi.org\/10.1002\/mdc3.12804.","journal-title":"Movement Disorders Clinical Practice"},{"issue":"8","key":"1424_CR9","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s00415-020-09815-2","volume":"268","author":"A Diallo","year":"2021","unstructured":"Diallo A, Jacobi H, Tezenas du Montcel S, Klockgether T. Natural history of most common spinocerebellar ataxia: a systematic review and meta-analysis. J Neurol. 2021;268(8):2749\u201356. https:\/\/doi.org\/10.1007\/s00415-020-09815-2.","journal-title":"J Neurol"},{"issue":"3","key":"1424_CR10","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000155","volume":"3","author":"KP Figueroa","year":"2017","unstructured":"Figueroa KP, Coon H, Santos N, Velazquez L, Mederos LA, Pulst SM. Genetic analysis of age at onset variation in spinocerebellar ataxia type 2. Neurology Genetics. 2017;3(3):e155. https:\/\/doi.org\/10.1212\/NXG.0000000000000155.","journal-title":"Neurology Genetics"},{"issue":"2","key":"1424_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/mds.27915","volume":"35","author":"KZ Gajos","year":"2020","unstructured":"Gajos KZ, Reinecke K, Donovan M, Stephen CD, Hung AY, Schmahmann JD, Gupta AS. Computer mouse use captures ataxia and parkinsonism, enabling accurate measurement and detection. Mov Disord. 2020;35(2):354\u20138. https:\/\/doi.org\/10.1002\/mds.27915.","journal-title":"Mov Disord"},{"issue":"5","key":"1424_CR12","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/mds.28478","volume":"36","author":"M Grobe-Einsler","year":"2021","unstructured":"Grobe-Einsler M, Taheri Amin A, Faber J, Schaprian T, Jacobi H, Schmitz-H\u00fcbsch T, Diallo A, Tezenas du Montcel S, Klockgether T. Development of SARA home, a new video-based tool for the assessment of ataxia at home. Mov Disord. 2021;36(5):1242\u20136. https:\/\/doi.org\/10.1002\/mds.28478.","journal-title":"Mov Disord"},{"issue":"1","key":"1424_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/brain\/awx317","volume":"141","author":"F Hoche","year":"2018","unstructured":"Hoche F, Guell X, Vangel MG, Sherman JC, Schmahmann JD. The cerebellar cognitive affective\/Schmahmann Syndrome Scale. Brain. 2018;141(1):248\u201370. https:\/\/doi.org\/10.1093\/brain\/awx317.","journal-title":"Brain"},{"key":"1424_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nicl.2016.11.007","volume":"13","author":"S-R Huang","year":"2017","unstructured":"Huang S-R, Wu Y-T, Jao C-W, Soong B-W, Lirng J-F, Wu H-M, Wang P-S. CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3. NeuroImage: Clinical. 2017;13:97\u2013105. https:\/\/doi.org\/10.1016\/j.nicl.2016.11.007.","journal-title":"NeuroImage: Clinical"},{"issue":"11","key":"1424_CR15","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1212\/WNL.0b013e31822e7ca0","volume":"77","author":"H Jacobi","year":"2011","unstructured":"Jacobi H, Bauer P, Giunti P, Labrum R, Sweeney MG, Charles P, Durr A, Marelli C, Globas C, Linnemann C, Schols L, Rakowicz M, Rola R, Zdzienicka E, Schmitz-Hubsch T, Fancellu R, Mariotti C, Tomasello C, Baliko L, et al. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology. 2011;77(11):1035\u201341. https:\/\/doi.org\/10.1212\/WNL.0b013e31822e7ca0.","journal-title":"Neurology"},{"issue":"11","key":"1424_CR16","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S1474-4422(15)00202-1","volume":"14","author":"H Jacobi","year":"2015","unstructured":"Jacobi H, du Montcel ST, Bauer P, Giunti P, Cook A, Labrum R, Parkinson MH, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Rakowicz M, Sulek A, Sobanska A, Schmitz-H\u00fcbsch T, Sch\u00f6ls L, et al. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. The Lancet Neurology. 2015;14(11):1101\u20138. https:\/\/doi.org\/10.1016\/S1474-4422(15)00202-1.","journal-title":"The Lancet Neurology"},{"issue":"4","key":"1424_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1468-1331.2008.02078.x","volume":"15","author":"C Kieling","year":"2008","unstructured":"Kieling C, Rieder CRM, Silva ACF, Saute JAM, Cecchin CR, Monte TL, Jardim LB. A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3). Eur J Neurol. 2008;15(4):371\u20136. https:\/\/doi.org\/10.1111\/j.1468-1331.2008.02078.x.","journal-title":"Eur J Neurol"},{"issue":"7","key":"1424_CR18","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1212\/01.WNL.0000055089.39373.FC","volume":"60","author":"C Lamperti","year":"2003","unstructured":"Lamperti C, Naini A, Hirano M, De Vivo DC, Bertini E, Servidei S, Valeriani M, Lynch D, Banwell B, Berg M, Dubrovsky T, Chiriboga C, Angelini C, Pegoraro E, DiMauro S. Cerebellar ataxia and coenzyme Q10 deficiency. Neurology. 2003;60(7):1206\u20138. https:\/\/doi.org\/10.1212\/01.WNL.0000055089.39373.FC.","journal-title":"Neurology"},{"issue":"4","key":"1424_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"D Langbehn","year":"2004","unstructured":"Langbehn D, Brinkman R, Falush D, Paulsen J, Hayden M, on behalf of an International Huntington\u2019s Disease Collaborative Group. A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length: prediction of the age of onset and penetrance for HD. Clin Genet. 2004;65(4):267\u201377. https:\/\/doi.org\/10.1111\/j.1399-0004.2004.00241.x.","journal-title":"Clin Genet"},{"issue":"1","key":"1424_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ana.25919","volume":"89","author":"VB Leotti","year":"2021","unstructured":"Leotti VB, Vries JJ, Oliveira CM, Mattos EP, Te Meerman GJ, Brunt ER, Kampinga HH, Jardim LB, Verbeek DS. CAG repeat size influences the progression rate of spinocerebellar ataxia type 3. Ann Neurol. 2021;89(1):66\u201373. https:\/\/doi.org\/10.1002\/ana.25919.","journal-title":"Ann Neurol"},{"key":"1424_CR21","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fneur.2020.00902","volume":"11","author":"C-C Lin","year":"2020","unstructured":"Lin C-C, Ashizawa T, Kuo S-H. Collaborative efforts for spinocerebellar ataxia research in the United States: CRC-SCA and READISCA. Front Neurol. 2020;11:902. https:\/\/doi.org\/10.3389\/fneur.2020.00902.","journal-title":"Front Neurol"},{"issue":"2","key":"1424_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/mds.26088","volume":"30","author":"RY Lo","year":"2015","unstructured":"Lo RY, Figueroa KP, Pulst SM, Lin C-Y, Perlman S, Wilmot G, Gomez C, Schmahmann J, Paulson H, Shakkottai VG, Ying S, Zesiewicz T, Bushara K, Geschwind M, Xia G, Subramony SH, Ashizawa T, Kuo S-H. Coenzyme Q10 and spinocerebellar ataxias: coenzyme Q10 and spinocerebellar ataxias. Mov Disord. 2015;30(2):214\u201320. https:\/\/doi.org\/10.1002\/mds.26088.","journal-title":"Mov Disord"},{"issue":"9","key":"1424_CR23","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1007\/s00415-021-10516-7","volume":"268","author":"RPPWM Maas","year":"2021","unstructured":"Maas RPPWM, Killaars S, van de Warrenburg BPC, Schutter DJLG. The cerebellar cognitive affective syndrome scale reveals early neuropsychological deficits in SCA3 patients. J Neurol. 2021;268(9):3456\u201366. https:\/\/doi.org\/10.1007\/s00415-021-10516-7.","journal-title":"J Neurol"},{"issue":"5","key":"1424_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1177\/1545968311425918","volume":"26","author":"I Miyai","year":"2012","unstructured":"Miyai I, Ito M, Hattori N, Mihara M, Hatakenaka M, Yagura H, Sobue G, Nishizawa M. Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases. Neurorehabil Neural Repair. 2012;26(5):515\u201322. https:\/\/doi.org\/10.1177\/1545968311425918.","journal-title":"Neurorehabil Neural Repair"},{"issue":"1","key":"1424_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13023-017-0725-y","volume":"13","author":"TL Monte","year":"2018","unstructured":"Monte TL, da Reckziegel ER, Augustin MC, Locks-Coelho LD, Santos ASP, Furtado GV, de Mattos EP, Pedroso JL, Barsottini OP, Vargas FR, Saraiva-Pereira M-L, Camey SA, Leotti VB, Jardim LB, on behalf of Rede Neurogen\u00e9tica. The progression rate of spinocerebellar ataxia type 2 changes with stage of disease. Orphanet Journal of Rare Diseases. 2018;13(1):20. https:\/\/doi.org\/10.1186\/s13023-017-0725-y.","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"1424_CR26","unstructured":"Opal, P., & Ashizawa, T. (1993). Spinocerebellar ataxia type 1. In M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. Bean, G. Mirzaa, & A. Amemiya (Eds.), GeneReviews\u00ae. University of Washington, Seattle. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1184\/"},{"issue":"1","key":"1424_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","volume":"30","author":"HT Orr","year":"2007","unstructured":"Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci. 2007;30(1):575\u2013621. https:\/\/doi.org\/10.1146\/annurev.neuro.29.051605.113042.","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"1424_CR28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s12311-010-0213-6","volume":"10","author":"G \u00d6z","year":"2011","unstructured":"\u00d6z G, Iltis I, Hutter D, Thomas W, Bushara KO, Gomez CM. Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy. Cerebellum. 2011;10(2):208\u201317. https:\/\/doi.org\/10.1007\/s12311-010-0213-6.","journal-title":"Cerebellum"},{"key":"1424_CR29","unstructured":"Paulson H, Shakkottai V (1993). Spinocerebellar ataxia type 3. In M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. Bean, G. Mirzaa, & A. Amemiya (Eds.), GeneReviews\u00ae. University of Washington, Seattle. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1196\/"},{"key":"1424_CR30","doi-asserted-by":"crossref","unstructured":"Pulst SM (1993). Spinocerebellar ataxia type 2. In M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. Bean, G. Mirzaa, & A. Amemiya (Eds.), GeneReviews\u00ae. University of Washington, Seattle. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1275\/","DOI":"10.1038\/ng0993-8c"},{"issue":"3","key":"1424_CR31","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/brain\/aws369","volume":"136","author":"K Reetz","year":"2013","unstructured":"Reetz K, Costa AS, Mirzazade S, Lehmann A, Juzek A, Rakowicz M, Boguslawska R, Sch\u00f6ls L, Linnemann C, Mariotti C, Grisoli M, D\u00fcrr A, van de Warrenburg BP, Timmann D, Pandolfo M, Bauer P, Jacobi H, Hauser T-K, Klockgether T, et al. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. Brain. 2013;136(3):905\u201317. https:\/\/doi.org\/10.1093\/brain\/aws369.","journal-title":"Brain"},{"issue":"9","key":"1424_CR32","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/mds.27437","volume":"33","author":"JC Rodr\u00edguez-D\u00edaz","year":"2018","unstructured":"Rodr\u00edguez-D\u00edaz JC, Vel\u00e1zquez-P\u00e9rez L, Rodr\u00edguez Labrada R, Aguilera Rodr\u00edguez R, Laffita P\u00e9rez D, Canales Ochoa N, Medrano Montero J, Estupi\u00f1\u00e1n Rodr\u00edguez A, Osorio Borjas M, G\u00f3ngora Marrero M, Reynaldo Cejas L, Gonz\u00e1lez Zaldivar Y, Almaguer Gotay D. Neurorehabilitation therapy in spinocerebellar ataxia type 2: a 24-week, rater-blinded, randomized, controlled trial: neurorehabilitation in SCA2. Mov Disord. 2018;33(9):1481\u20137. https:\/\/doi.org\/10.1002\/mds.27437.","journal-title":"Mov Disord"},{"key":"1424_CR33","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez-Labrada R, Batista-Izquierdo A, Gonz\u00e1lez-Melix Z, Reynado-Cejas L, V\u00e1zquez-Mojena Y, Sanz YA, Canales-Ochoa N, Gonz\u00e1lez-Zald\u00edvar Y, Dogan I, Reetz K, Vel\u00e1zquez-P\u00e9rez L (2021). Cognitive decline is closely associated with ataxia severity in spinocerebellar ataxia type 2: a validation study of the Schmahmann Syndrome Scale. The Cerebellum. https:\/\/doi.org\/10.1007\/s12311-021-01305-z","DOI":"10.1007\/s12311-021-01305-z"},{"issue":"12","key":"1424_CR34","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/mds.22681","volume":"24","author":"JD Schmahmann","year":"2009","unstructured":"Schmahmann JD, Gardner R, MacMore J, Vangel MG. Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS: Brief Ataxia Rating Scale. Mov Disord. 2009;24(12):1820\u20138. https:\/\/doi.org\/10.1002\/mds.22681.","journal-title":"Mov Disord"},{"key":"1424_CR35","doi-asserted-by":"publisher","unstructured":"Schmahmann JD, Pierce S, MacMore J, L\u2019Italien GJ (2021). Development and validation of a patient-reported outcome measure of ataxia. Movement Disorders, mds.28670. https:\/\/doi.org\/10.1002\/mds.28670","DOI":"10.1002\/mds.28670"},{"issue":"11","key":"1424_CR36","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-H\u00fcbsch","year":"2006","unstructured":"Schmitz-H\u00fcbsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang J-S, Kremer B, Mariotti C, Melegh B, Pandolfo M, Rakowicz M, Ribai P, Rola R, Schols L, Szymanski S, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717\u201320. https:\/\/doi.org\/10.1212\/01.wnl.0000219042.60538.92.","journal-title":"Neurology"},{"issue":"12","key":"1424_CR37","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1002\/mds.28740","volume":"36","author":"VV Shah","year":"2021","unstructured":"Shah VV, Rodriguez-Labrada R, Horak FB, McNames J, Casey H, Hansson Floyd K, El-Gohary M, Schmahmann JD, Rosenthal LS, Perlman S, Vel\u00e1zquez-P\u00e9rez L, Gomez CM. Gait variability in spinocerebellar ataxia assessed using wearable inertial sensors. Mov Disord. 2021;36(12):2922\u201331. https:\/\/doi.org\/10.1002\/mds.28740.","journal-title":"Mov Disord"},{"issue":"7","key":"1424_CR38","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1212\/01.WNL.0000156802.15466.79","volume":"64","author":"SH Subramony","year":"2005","unstructured":"Subramony SH, May W, Lynch D, Gomez C, Fischbeck K, Hallett M, Taylor P, Wilson R, Ashizawa T, for the Cooperative Ataxia Group. Measuring Friedreich ataxia: interrater reliability of a neurologic rating scale. Neurology. 2005;64(7):1261\u20132. https:\/\/doi.org\/10.1212\/01.WNL.0000156802.15466.79.","journal-title":"Neurology"},{"issue":"5","key":"1424_CR39","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/brain\/awn059","volume":"131","author":"S Tezenas du Montcel","year":"2008","unstructured":"Tezenas du Montcel S, Charles P, Ribai P, Goizet C, Le Bayon A, Labauge P, Guyant-Mar\u00e9chal L, Forlani S, Jauffret C, Vandenberghe N, N\u2019Guyen K, Le Ber I, Devos D, Vincitorio C-M, Manto M-U, Tison F, Hannequin D, Ruberg M, Brice A, Durr A. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment. Brain. 2008;131(5):1352\u201361. https:\/\/doi.org\/10.1093\/brain\/awn059.","journal-title":"Brain"},{"issue":"9","key":"1424_CR40","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1093\/brain\/awu174","volume":"137","author":"S Tezenas du Montcel","year":"2014","unstructured":"Tezenas du Montcel S, Durr A, Bauer P, Figueroa KP, Ichikawa Y, Brussino A, Forlani S, Rakowicz M, Sch\u00f6ls L, Mariotti C, van de Warrenburg BPC, Orsi L, Giunti P, Filla A, Szymanski S, Klockgether T, Berciano J, Pandolfo M, Boesch S, et al. Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. Brain. 2014a;137(9):2444\u201355. https:\/\/doi.org\/10.1093\/brain\/awu174.","journal-title":"Brain"},{"issue":"7","key":"1424_CR41","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1136\/jmedgenet-2013-102200","volume":"51","author":"S Tezenas du Montcel","year":"2014","unstructured":"Tezenas du Montcel S, Durr A, Rakowicz M, Nanetti L, Charles P, Sulek A, Mariotti C, Rola R, Schols L, Bauer P, Dufaure-Gar\u00e9 I, Jacobi H, Forlani S, Schmitz-H\u00fcbsch T, Filla A, Timmann D, van de Warrenburg BP, Marelli C, Kang J-S, et al. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. J Med Genet. 2014b;51(7):479\u201386. https:\/\/doi.org\/10.1136\/jmedgenet-2013-102200.","journal-title":"J Med Genet"},{"issue":"2","key":"1424_CR42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0022-510X(96)00231-6","volume":"145","author":"P Trouillas","year":"1997","unstructured":"Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, Bryer A, Diener HC, Massaquoi S, Gomez CM, Coutinho P, Hamida MB, Campanella G, Filla A, Schut L, Timann D, Honnorat J, Nighoghossian N, Manyam B. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci. 1997;145(2):205\u201311. https:\/\/doi.org\/10.1016\/S0022-510X(96)00231-6.","journal-title":"J Neurol Sci"},{"key":"1424_CR43","doi-asserted-by":"publisher","unstructured":"Zhou H, Nguyen H, Enriquez A, Morsy L, Curtis M, Piser T, Kenney C, Stephen CD, Gupta AS, Schmahmann JD, Vaziri A. (2021). Assessment of gait and balance impairment in people with spinocerebellar ataxia using wearable sensors. Neurological Sciences. https:\/\/doi.org\/10.1007\/s10072-021-05657-6","DOI":"10.1007\/s10072-021-05657-6"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-022-01424-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-022-01424-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-022-01424-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T08:33:38Z","timestamp":1694075618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-022-01424-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["1424"],"URL":"https:\/\/doi.org\/10.1007\/s12311-022-01424-1","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"assertion":[{"value":"25 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"E.M.R. serves on the BrainSpec Inc. Scientific Advisory Board. G.\u00d6. consults for IXICO Technologies Limited and uniQure biopharma B.V., serves on the Scientific Advisory Board of BrainSpec Inc., and receives research support from Biogen. J.D.S. is site PI for Biohaven Pharma, consults for Biogen and MedAvante, and holds the copyright with the General Hospital Corporation to the Brief Ataxia Rating scale, Patient Reported outcome Measure of Ataxia, and the Cerebellar Cognitive Affective\/Schmahmann Syndrome Scale.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}